Bricks Lucia Ferro
Children's Institute, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo/SP, Brazil.
Rev Hosp Clin Fac Med Sao Paulo. 2003 Sep-Oct;58(5):263-74. doi: 10.1590/s0041-87812003000500006. Epub 2003 Nov 11.
Neonates and young children remain susceptible to many serious infectious diseases preventable through vaccination. In general, current vaccines strategies to prevent infectious diseases are unable to induce protective levels of antibodies in the first 6 months of life. Women vaccinated during pregnancy are capable of producing immunoglobulin antibodies that are transported actively to the fetus, and maternal immunization can benefit both the mother and the child. With few exceptions, maternal immunization is not a routine, because of the concerns related to the safety of this intervention. Ethical and cultural issues make the studies on maternal immunization difficult; however, in the last decade, the development of new vaccines, which are very immunogenic and safe has reactivated the discussions on maternal immunization. In this paper we present a review of the literature about maternal immunization based on MEDLINE data (1990 to 2002). The most important conclusions are: 1) there is no evidence of risk to the fetus by immunizing pregnant women with toxoids, polysaccharide, polysaccharide conjugated and inactive viral vaccines; 2) most viral attenuated vaccines are probably safe too, but data is still insufficient to demonstrate their safety; therefore these vaccines should be avoided in pregnant women; 3) in Brazil, there is a need for a maternal immunization program against tetanus. Many new candidate vaccines for maternal immunization are available, but studies should be conducted to evaluate their safety and efficacy, as well as regional priorities based on epidemiological data.
新生儿和幼儿仍然易患许多可通过疫苗预防的严重传染病。一般来说,目前预防传染病的疫苗策略在生命的头6个月内无法诱导出具有保护作用的抗体水平。孕期接种疫苗的女性能够产生免疫球蛋白抗体,这些抗体可主动转运至胎儿体内,母体免疫对母亲和孩子都有益处。除了少数例外情况,由于对这种干预措施安全性的担忧,母体免疫并非常规做法。伦理和文化问题使得母体免疫研究困难重重;然而,在过去十年中,新型疫苗的研发,这些疫苗具有很强的免疫原性且安全,重新引发了关于母体免疫的讨论。在本文中,我们基于MEDLINE数据(1990年至2002年)对有关母体免疫的文献进行了综述。最重要的结论是:1)用类毒素、多糖、多糖结合和灭活病毒疫苗给孕妇接种疫苗,没有证据表明对胎儿有风险;2)大多数减毒活疫苗可能也是安全的,但数据仍不足以证明其安全性;因此,孕妇应避免使用这些疫苗;3)在巴西,需要开展一项针对破伤风的母体免疫计划。有许多用于母体免疫的新候选疫苗,但应开展研究以评估其安全性和有效性,以及基于流行病学数据的区域优先事项。